Table 1.
General treatment schedule without HLA test | HLA-guided treatment schedule | |
---|---|---|
Cost per patient/10 years (JPN/UK) | £16,487/£4211 | £16,552/£4281 |
Incremental Cost (JPN/UK) | £65/£70 | |
Effect per patient/10 years (QALYs: JPN/UK) | 6.22608/5.82665 | 6.22917/5.82990 |
Incremental effect (QALYs: JPN/UK) | 0.00309/0.00326 | |
ICER (JPN/UK) | £21,024/£21,343 |
JPN Japan, UK United Kingdom, QALY quality-adjusted life years, ICER incremental cost-effectiveness ratio.